(N = 61) | |
Side effect | No of patients |
Neurotoxicity | 14 (23%) |
Thrombocytopenia | 9 (15%) |
Respiratory problems, allergic reaction | 3 (5%) |
Weakness | 1 (2%) |
Severe dehydration, vomiting, diarrhea | 3 (5%) |
The patient should not have more oxaliplatin because of side effects | 1 (2%) |
No documented cause, only documented that the treatment is interrupted | 29 (48%) |
Sum of interrupted treatment; | 60 (98%) |